// App-Quantinova.ai

AB0429 (2018) : No difference in effectiveness with either etanercept originator or biosimilar as first line biologic treatment for rheumatoid arthritis

Researchers

Presenter

  • D. De Cock

Principal Investigators

  • R. Davies

  • L. Kearsley-Fleet

  • K. Watson

  • K. Hyrich

Medical Centers

  • Arthritis Research UK Centre for Epidemiology, Manchester, United Kingdom

  • Manchester Academic Health Science Centre, Central Manchester NHS Foundation Trust, Manchester, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved